Protide Pharmaceuticals Inc (PPMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 02-2004 | 11-2003 | 08-2003 | 05-2003 | 02-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10 | -30 | N/A | -50 | -20 |
| Depreciation Amortization | 10 | 5 | N/A | 20 | 10 |
| Other Working Capital | -20 | -9 | N/A | -20 | -20 |
| Other Operating Activity | 0 | 4 | 0 | 0 | 0 |
| Operating Cash Flow | $-20 | $-30 | $N/A | $-50 | $-30 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | N/A | -3 | 0 |
| Other Investing Activity | 10 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $10 | $0 | $N/A | $-3 | $0 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $0 | $0 | $N/A | $0 | $0 |
| Beginning Cash Position | 110 | 110 | N/A | 200 | 200 |
| End Cash Position | 110 | 80 | N/A | 140 | 160 |
| Net Cash Flow | $-9 | $-30 | $N/A | $-50 | $-30 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20 | -30 | N/A | -50 | -30 |
| Free Cash Flow | -20 | -30 | 0 | -50 | -30 |